BriaCell Therapeutics Corp. Quarterly Current Ratio in % from Q1 2023 to Q3 2024

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
BriaCell Therapeutics Corp. quarterly Current Ratio history and growth rate from Q1 2023 to Q3 2024.
  • BriaCell Therapeutics Corp. Current Ratio for the quarter ending October 31, 2024 was 126 %, a 94.3% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 126 -2.09K -94.3% Oct 31, 2024
Q2 2024 205 -2.46K -92.3% Jul 31, 2024
Q1 2024 463 -3.17K -87.2% Apr 30, 2024
Q4 2023 1.06K Jan 31, 2024
Q3 2023 2.22K Oct 31, 2023
Q2 2023 2.66K Jul 31, 2023
Q1 2023 3.63K Apr 30, 2023
* An asterisk sign (*) next to the value indicates that the value is likely invalid.